About Alector (ALEC)
Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologi... Read more
- USD5.33
- USD5.33
- USD5.06
- USD9.07
- -17.20%
- 97M
- 596.55k
- 576M
- 3.66
- -25.10%
Stock News
3 hours ago
High rates haven't always been a problem for stocks
Yahoo
3 hours ago
Heard on the Street Wednesday Recap: Equities Losing Favor?
Yahoo
3 hours ago
Alcoa Corp (AA) Q1 2024 Earnings Call Transcript Highlights: Navigating Market Dynamics and ...
Yahoo
4 hours ago
Why Snap Stock Soared Nearly 5% Higher on Wednesday
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
